Cost-Effectiveness Study of HPV Vaccination as a Primary Prevention Strategy for Anal Cancer in HIV-Positive Men in Chile

Thumbnail Image
File version
Vargas Parada, C
Lennert Veerman, J
Griffith University Author(s)
Primary Supervisor
Other Supervisors
File type(s)

Background: Most anal cancers are caused by the human papilloma virus (HPV) infection. The incidence is increasing, especially in high-risk individuals such as HIV-positive men. Evidence shows that the new quadrivalent HPV vaccine reduces the rates of anal intraepithelial neoplasia among men who have sex with men. Objective: To determine whether vaccinating against HPV-related anal cancer is cost-effective in HIV-positive men in Chile. Methods: A cost-effectiveness analysis was conducted by constructing a cohort multistate life-table–based Markov model in MS Excel in which the prevention of HPV infection was expected to influence the incidence of anal cancer in HIV-positive men. The comparator was the current practice of no systematic HPV prevention. Estimates of the efficacy of the vaccine were obtained from a substudy of a larger randomized controlled trial, incidence rates from the Chilean Population Cancer Registries, mortality rates from the National Institute of Statistics, and disease costs from a cost-effectiveness report. A public health care sector perspective was applied. The outcome was measured in averted disability-adjusted life-years. The incremental costeffectiveness ratio was calculated considering a lifetime horizon for costs and health outcomes. Results: The estimated incremental costeffectiveness ratio was US $138,269/ disability-adjusted life-year (95% confidence interval $95,936–$221,862). Assuming a threshold of 3 times the gross domestic product per capita, the intervention was not costeffective. The outcome was sensitive to the vaccine price and vaccine efficacy. Conclusions: HPV vaccination in HIV-positive men from a Chilean public health care sector perspective is not cost-effective.

Journal Title

Value in Health Regional Issues

Conference Title
Book Title


Thesis Type
Degree Program
Publisher link
Patent number
Grant identifier(s)
Rights Statement
Rights Statement

© 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence, which permits unrestricted, non-commercial use, distribution and reproduction in any medium, providing that the work is properly cited.

Item Access Status
Access the data
Related item(s)

Pharmacology and pharmaceutical sciences

Health services and systems

Public health

Applied economics

Health economics

Persistent link to this record